ceftriaxone + ciprofloxacin + meropenem + vancomycin

A combination antibiotic therapy consisting of four different antimicrobial agents:

1. Ceftriaxone: A third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis. It has broad-spectrum activity against many Gram-positive and Gram-negative bacteria. 2. Ciprofloxacin: A fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication. It has excellent activity against many Gram-negative organisms, including Pseudomonas aeruginosa. 3. Meropenem: A carbapenem antibiotic with ultra-broad spectrum activity against Gram-positive and Gram-negative bacteria, including many multidrug-resistant organisms. 4. Vancomycin: A glycopeptide antibiotic that inhibits cell wall synthesis in Gram-positive bacteria, particularly effective against methicillin-resistant Staphylococcus aureus (MRSA).

This combination provides extremely broad antimicrobial coverage and is typically used for empiric therapy in critically ill patients with suspected severe infections, particularly when multidrug-resistant organisms are a concern.